英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
ffnet查看　ffnet　在百度字典中的解释百度英翻中〔查看〕
ffnet查看　ffnet　在Google字典中的解释Google英翻中〔查看〕
ffnet查看　ffnet　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • How effective is Ingrezza? - Drugs. com
    Weight gain has been reported in a 6-week clinical study with Ingrezza, but it is not a common side effect Of 151 patients taking either the 40 mg day or 80 mg day dose, 3 patients had weight gain (2%) compared to zero patients (0%) in the placebo (inactive treatment) group
  • How Ingrezza Works for Tardive Dyskinesia and Chorea - WebMD
    Ingrezza (in-GREH-zah) was approved in 2017 as the first medicine to help control movement in people with tardive dyskinesia and was approved for use in people with chorea caused by Huntington’s
  • Ingrezza: Uses, Side Effects, Dosage, Cost, and More - Healthline
    Before starting Ingrezza treatment, be sure to tell your doctor about all medications you take, including prescription and over-the-counter kinds Also describe any vitamins, herbs, or supplements
  • How INGREZZA Can Help | INGREZZA® (valbenazine) capsules
    3 simple and effective dosing options; Starts at an effective dose; What makes INGREZZA different? Unlike other TD medications, INGREZZA selectively and specifically targets a protein called VMAT2 ‖ VMAT2 aids in the release of dopamine ‖ Based on laboratory tests This does not imply a treatment advantage How INGREZZA works:
  • Neurocrine Biosciences Presents New Data Showing Significant . . .
    INGREZZA is a selective vesicular monoamine transporter 2 (VMAT2) inhibitor approved by the U S Food and Drug Administration for the treatment of adults with tardive dyskinesia and the treatment





中文字典-英文字典  2005-2009